Clinical Trials Directory

Trials / Completed

CompletedNCT02614885

Feasibility Study of Cavitary Radiofrequency Ablation in Excised Mastectomy Breast Tissue

Status
Completed
Phase
Study type
Observational
Enrollment
11 (actual)
Sponsor
Innoblative Designs, Inc. · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a single-arm, prospective study of a radiofrequency ablation device on the excised breast tissue of ten (10) prophylactic mastectomy patients. The ablation lesion created by the device will be analyzed histologically.

Detailed description

This study is a single-center, prospective, open label study of a radiofrequency ablation device. 10 patients who are scheduled to undergo prophylactic mastectomy will be recruited by the clinical investigators at the investigational site in accordance with the inclusion and exclusion criteria. Once the breast tissue is removed, the radiofrequency ablation device will be used on the ex vivo tissue to ablate a lesion around a cavity created in the tissue. The ablation lesion will be characterized. The study period per subject is the time it takes to assess the ablation lesion histologically.

Conditions

Interventions

TypeNameDescription
DEVICERFARadiofrequency ablation of the cavity walls of a simulated lumpectomy in the excised prophylactic mastectomy tissue.

Timeline

Start date
2016-07-20
Primary completion
2017-06-15
Completion
2017-08-17
First posted
2015-11-25
Last updated
2017-11-14

Source: ClinicalTrials.gov record NCT02614885. Inclusion in this directory is not an endorsement.